NEUROFIT
Created in 1996
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
1,001Activities
Technologies
Entity types
Location
850 Bd Sébastien Brant, 67400 Illkirch-Graffenstaden, France
Illkirch-Graffenstaden
France
Employees
Scale: 11-50
Estimated: 31
SIREN
480329200Engaged corporates
4
0 1Added in Motherbase
3 years, 10 months ago
biotech Value proposition
Providing efficient preclinical research models for central nervous system and peripheral nervous system disorders.
NEUROFIT, founded in 1996, is a pre-clinical CRO (Contract Research Organization) based in France and offering a comprehensive list of disease models and screening assays in the fields of psychiatry, neurology, multiple sclerosis, diabetes and pain. Neurofit works for major pharmaceutical and Biotech companies in Europe and the USA.
Neurofit’s core expertise in CNS and PNS includes animal behavior techniques, nerve conduction velocity measure, nerve fiber morphometry, primary neuronal cell cultures. Neurofit has long-standing experiences in psychiatric, neurodegenerative and autoimmune / inflammatory disorders. Our disease models are clinically relevant and predictive.
Neurofit routinely performs, as part of a study, collection of blood, serum plasma, cerebrospinal fluid as well as dissection of brain microstructures from compound-treated animals to provide customers with useful samples for their pharmacokinetic, biochemistry and immunochemistry analyses.
Preclinical CRO, Drug screening, Disease models, Central and peripheral nervous system disorders, CNS and PNS, Auto-immune diseases, Translational models, Translational studies, In Vivo, In Vitro, Neurocellular models, Rodents models, Behavioral tests, and Rats and Mice modelsOriginal language
Providing efficient preclinical research models for central nervous system and peripheral nervous system disorders.
NEUROFIT, founded in 1996, is a pre-clinical CRO (Contract Research Organization) based in France and offering a comprehensive list of disease models and screening assays in the fields of psychiatry, neurology, multiple sclerosis, diabetes and pain. Neurofit works for major pharmaceutical and Biotech companies in Europe and the USA.
Neurofit’s core expertise in CNS and PNS includes animal behavior techniques, nerve conduction velocity measure, nerve fiber morphometry, primary neuronal cell cultures. Neurofit has long-standing experiences in psychiatric, neurodegenerative and autoimmune / inflammatory disorders. Our disease models are clinically relevant and predictive.
Neurofit routinely performs, as part of a study, collection of blood, serum plasma, cerebrospinal fluid as well as dissection of brain microstructures from compound-treated animals to provide customers with useful samples for their pharmacokinetic, biochemistry and immunochemistry analyses.
NEUROFIT - Preclinical Contract Research Organization (CRO) for CNS and PNS disorders
NEUROFIT is a preclinical Contract Research Organization specialising in the evaluation of treatments for central and peripheral nervous system disorders. We offer a comprehensive list of in vitro and in vivo models covering a wide range of indications. NEUROFIT aims to facilitate your preclinical drug development by proposing the best models for your needs. Our goal is to accelerate the development of your programs by providing cost-effective methods for compound evaluation.
https://www.neurofit.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 CNRS Research, Research Services | CNRS Research, Research Services | Other 9 Mar 2024 | | |
 Merck Group Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing | Merck Group Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing | Other 9 Mar 2024 | | |
 Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Other 9 Mar 2024 | | |
 Ipsen Pharmaceutical, Pharmaceutical Manufacturing | Ipsen Pharmaceutical, Pharmaceutical Manufacturing | Other 31 Oct 2021 | | |